Diagnosis and risk stratification in patients with acute coronary syndromes according to ESC guidelines

被引:2
|
作者
Klein, W [1 ]
Hödl, R [1 ]
Kraxner, W [1 ]
机构
[1] Karl Franzens Univ Graz, Sch Med, Dept Internal Med, Div Cardiol, A-8036 Graz, Austria
关键词
acute coronary syndrome; unstable angina; myocardial infarction; risk stratification; diagnosis;
D O I
10.1016/S0049-3848(01)00298-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diagnosis and risk stratification of patients with acute coronary syndromes remain extremely important in order to avoid unnecessary hospitalizations on the one hand, and to improve prognosis of these patients on the other. For diagnosis of acute coronary syndromes, an ECG should be obtained at rest, troponin T and I should be measured on admission and again 6 to 12 h later, and myoglobin or CK-MB should be determined in patients with recent syndromes and those with recurring ischemia. Risk should be assessed upon admission and repeatedly during the hospital stay. Early risk indicators are: age, mate sex, previous manifestation of coronary artery disease, history of left ventricular dysfunction or congestive heart failure and ongoing chest pain, as well as ST depression, transient ST segment elevation, and elevated levels of troponin T or I. Longer term risk assessment in unstable coronary artery disease includes rest and stress echocardiography, exercise ECG, thallium scintigraphy, as well as coronary angiography and left ventriculography. Markers of high long-term risk are old age, prior history of myocardial infarction, diabetes, elevated levels of C-reactive protein, and the extent of coronary artery disease and left ventricular dysfunction. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:S57 / S61
页数:5
相关论文
共 50 条
  • [42] Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better
    Yan, Andrew T.
    Yan, Raymond T.
    Tan, Mary
    Casanova, Amparo
    Labinaz, Marino
    Sridhar, Kumar
    Fitchett, David H.
    Langer, Anatoly
    Goodman, Shaun G.
    EUROPEAN HEART JOURNAL, 2007, 28 (09) : 1072 - 1078
  • [43] Comments on the 2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation
    Barrabes, Jose A.
    Cequier, Angel
    Bueno, Hector
    Fernandez Gonzalez, Angel L.
    Fernandez-Ortiz, Antonio
    Lidon, Rosa M.
    Marin, Francisco
    Sanchis, Juan
    Sionis, Alessandro
    de la Torre Hernandez, Jose M.
    Aboal Vinas, Jaime
    Abu-Assi, Emad
    Ariza Sole, Albert
    Diaz Castro, Oscar
    Ferreiro Gutierrez, Jose Luis
    Garca Lledo, Alberto
    Nunez Gil, Ivan
    Raposeiras Roubin, Sergio
    Rodriguez-Palomares, Jose F.
    Viana Tejedor, Ana
    Vivas Balcones, David
    Anguita, Manuel
    Cequier, Angel
    Alfonso, Fernando
    Badimon, Lina
    Barrabes, Jose A.
    Fernandez Lozano, Ignacio
    Juan Gomez de Diego, Jose
    Rodriguez Padial, Luis
    Alberto San Romn, Jose
    Sanchez, Pedro-Luis
    Sanchis, Juan
    Sionis, Alessandro
    REVISTA ESPANOLA DE CARDIOLOGIA, 2015, 68 (12): : 1061 - 1067
  • [44] Individualizing therapy in acute coronary syndromes: Using a multiple biomarker approach for diagnosis, risk stratification, and guidance of therapy
    Mo V.Y.
    de Lemos J.A.
    Current Cardiology Reports, 2004, 6 (4) : 273 - 278
  • [45] Acute coronary syndromes in diabetes: Biomarkers of endothelial injury improve risk stratification and help identify predictors of risk
    Hsu, Amber R. Cordola
    Fan, Wenjun
    Harrington, Douglas
    Wong, Nathan D.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2022, 16 (04)
  • [46] The management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: key points from the ESC 2020 Clinical Practice Guidelines for the general and emergency physician
    Nadarajah, Ramesh
    Gale, Chris
    CLINICAL MEDICINE, 2021, 21 (02) : E206 - E211
  • [47] The role of biomarkers in the diagnosis and risk stratification of acute coronary syndrome
    Chacko, Sanoj
    Haseeb, Sohaib
    Glover, Benedict M.
    Wallbridge, David
    Harper, Alan
    FUTURE SCIENCE OA, 2018, 4 (01):
  • [48] Risk stratification in non-ST elevation acute coronary syndromes: Risk scores, biomarkers and clinical judgment
    Corcoran, David
    Grant, Patrick
    Berry, Colin
    IJC HEART & VASCULATURE, 2015, 8 : 131 - 137
  • [49] Prognostic Biomarkers in Acute Coronary Syndromes: Risk Stratification Beyond Cardiac Troponins
    K. M. Eggers
    B. Lindahl
    Current Cardiology Reports, 2017, 19
  • [50] Prognostic Biomarkers in Acute Coronary Syndromes: Risk Stratification Beyond Cardiac Troponins
    Eggers, K. M.
    Lindahl, B.
    CURRENT CARDIOLOGY REPORTS, 2017, 19 (04)